Clinical Trials Browser

Interventional × Lymphatic Metastasis × 90 days × Clear all

NCT03793166 2026-03-18

Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study

Phase 3 Active not recruiting

Carcinoma, Renal Cell, Lymphatic Metastasis

NCT04071236 2026-03-18

Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy

Phase 1/2 Recruiting

Lymphatic Metastasis, Prostatic Neoplasms

NCT04221438 2026-03-12

Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement

Phase 2 Terminated

3 enrolled 11 charts

Lymphatic Metastasis, Melanoma

NCT06252129 2026-03-05

Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection Specimens

Phase NA Recruiting

Lung Neoplasms, Lymphatic Metastasis, Pathologic Processes

NCT01409200 2026-03-03

Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node Metastasis

Phase 2 Completed

Lymphatic Metastasis

NCT06264167 2026-02-20

NODE

Phase NA Recruiting

Lymphatic Metastasis, Vulvar Neoplasms

NCT05075980 2026-02-13

Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study

Phase 2 Recruiting

Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Lymphatic Metastasis, Mouth Neoplasms, Oropharyngeal Neoplasms, Paranasal Sinus Neoplasms, Salivary Gland Neoplasms

NCT03796767 2026-01-28

SOAR

Phase 2 Active not recruiting

20 enrolled 26 charts

Lymphatic Metastasis, Prostatic Neoplasms

NCT07362485 2026-01-23

INIGMA

Phase NA Recruiting

Breast Neoplasms, Lymphatic Metastasis

NCT07353294 2026-01-20

Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC

Phase 1 Not yet recruiting

Lymphatic Metastasis

NCT07025785 2026-01-15

Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer

Phase NA Recruiting

Breast Neoplasms, Lymphatic Metastasis, Neoplasm, Residual

NCT07146295 2026-01-12

INFINITE

Phase NA Recruiting

Breast Neoplasms, Lymphatic Metastasis

NCT07328243 2026-01-09

IRE-TCLN

Phase NA Recruiting

Lymphatic Metastasis